New Delhi: The Government of India has canceled the licenses of 18 pharma companies for manufacturing spurious drugs after the Drug Controller General of India (DCGI) inspected 76 companies from 20 states. Official sources gave this information on Tuesday.
According to sources, the government is taking strict action against the pharma companies manufacturing spurious medicines across the country. Officials said after inspection by state and central regulators, licenses of around 18 pharma companies were canceled for manufacturing spurious drugs.
The government of India canceled the licenses of 18 pharma companies for manufacturing spurious drugs after the Drugs Controller General of India (DCGI) inspected 76 companies in 20 states, the news agency quoted official sources as saying.
Sources said that a major crackdown is going on against the pharma companies across the country involved in the manufacturing of spurious drugs. Sources said that during the government crackdown on companies manufacturing spurious drugs, action has been taken against 70 companies in Himachal Pradesh, 45 in Uttarakhand, and 23 in Madhya Pradesh.
It may be noted that 18 children died in Uzbekistan last year after drinking cough syrup made by a Noida-based company in Uttar Pradesh. Since this incident, the government is taking action against the pharma companies making spurious medicines.
Significantly, the World Health Organization (WHO) issued an alert against substandard medicines manufactured by a Noida-based company. WHO said in its statement that the samples of Ambronol syrup and DOK-1 Max syrup manufactured by Marion Biotech were tested by the national quality control laboratories of the Ministry of Health of Uzbekistan. High levels of diethylene glycol and ethylene glycol were found in both drugs.
